Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Oxidative DNA Damage Biomarkers Used in Tissue Engineered Skin

Published

Author(s)

H Rodriguez, Pawel Jaruga, M Birincioglu, Peter E. Barker, C D. O'Connell, M. Dizdaroglu

Abstract

To assure that tissue engineered medical products are free of genetic changes that might occur from inflammation during the development phase of the product, our laboratory is responding to the need for test methods used to assess the safety and performance of tissue-engineered materials. Specifically, we are identifying cellular biomarkers that could be used during the in vitro development phase of tissue-engineered materials to ensure that cells have not undergone any inflammatory response during the development or shipment of the product. Using GC/MS technology, we have screened for a total of five genomic modified base DNA biomarkers in tissue-engineered skin and compared the levels to control cells, neonatal fibroblasts and neonatal keratinocytes. No significant level of damage was detected compared to control cells. Biomarker programs such as this can provide the basis for an international reference standard of cellular biomarkers that can aid in the development and safety of tissue engineered medical products.
Proceedings Title
Tissue Engineering, Stem Cells, and Gene Therapies
Volume
534
Conference Dates
September 19-22, 2002
Conference Location
Antalya,
Conference Title
9th International Symposium on Biomedical Science and Technology

Keywords

DNA damage, oxidative, tissue engineering

Citation

Rodriguez, H. , Jaruga, P. , Birincioglu, M. , Barker, P. , O'Connell, C. and Dizdaroglu, M. (2003), Oxidative DNA Damage Biomarkers Used in Tissue Engineered Skin, Tissue Engineering, Stem Cells, and Gene Therapies, Antalya, (Accessed May 30, 2024)

Issues

If you have any questions about this publication or are having problems accessing it, please contact reflib@nist.gov.

Created January 1, 2003, Updated February 19, 2017